Amit Singal

Amit Singal

University of Texas Southwestern Medical Center

H-index: 80

North America-United States

About Amit Singal

Amit Singal, With an exceptional h-index of 80 and a recent h-index of 71 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center, specializes in the field of Primary liver cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis

Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma

Initial uptake of durvalumab with or without tremelimumab for advanced hepatocellular carcinoma in routine clinical practice: Preliminary results of the international DT-real …

ASO Visual Abstract: Effect of Hospital Cancer Designation on Use of Multimodal Therapy and Survival of Patients with Metastatic Colorectal Cancer: A State-Wide Analysis

Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma

Association between bridging therapy and post-transplant outcomes in patients with hepatocellular carcinoma within Milan criteria: A systematic review and meta-analysis

Financial burden of hepatocellular carcinoma screening in patients with cirrhosis

Single-institutional analysis of radiotherapy and orthotopic liver transplant for patients with unresectable cholangiocarcinoma.

Amit Singal Information

University

Position

___

Citations(all)

27790

Citations(since 2020)

22148

Cited By

11582

hIndex(all)

80

hIndex(since 2020)

71

i10Index(all)

283

i10Index(since 2020)

264

Email

University Profile Page

University of Texas Southwestern Medical Center

Google Scholar

View Google Scholar Profile

Amit Singal Skills & Research Interests

Primary liver cancer

Top articles of Amit Singal

Title

Journal

Author(s)

Publication Date

Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis

Clinical Gastroenterology and Hepatology

Darine Daher

Karim Seif El Dahan

Alva Cano

Michael Gonzales

Crystal Ransom

...

2024/2/1

Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma

Digestive and Liver Disease

GF Manfredi

CAM Fulgenzi

A D'Alessio

C Celsa

B Stefanini

...

2024/2/1

Initial uptake of durvalumab with or without tremelimumab for advanced hepatocellular carcinoma in routine clinical practice: Preliminary results of the international DT-real …

Ciro Celsa

Naoshi Nishida

Ashwini Arvind

Susanna Varkey Ulahannan

Michael Li

...

2024/1/20

ASO Visual Abstract: Effect of Hospital Cancer Designation on Use of Multimodal Therapy and Survival of Patients with Metastatic Colorectal Cancer: A State-Wide Analysis

Annals of surgical oncology

Jennie Meier

Gilbert Murimwa

Mithin Nehrubabu

Lisa DiMartino

Amit G Singal

...

2024/2/17

Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma

Clinical Gastroenterology and Hepatology

Hidenori Toyoda

Mounika Kanneganti

Jonathan Melendez-Torres

Neehar D Parikh

Prasun K Jalal

...

2024/1/1

Association between bridging therapy and post-transplant outcomes in patients with hepatocellular carcinoma within Milan criteria: A systematic review and meta-analysis

Ashwini Arvind

Karim Seif El Dahan

Riya Malhotra

Darine Daher

Nicole E Rich

...

2024/3/5

Financial burden of hepatocellular carcinoma screening in patients with cirrhosis

Clinical Gastroenterology and Hepatology

Manasa Narasimman

Ruben Hernaez

Vanessa Cerda

MinJae Lee

Sruthi Yekkaluri

...

2024/4/1

Single-institutional analysis of radiotherapy and orthotopic liver transplant for patients with unresectable cholangiocarcinoma.

Meng-Lun Hsieh

Sumehra Hannan

Steven I Hanish

Parsia A Vagefi

Amit G Singal

...

2024/1/20

Accessibility to ERCP‐performing hospitals among patients with pancreatic cancer living in SEER regions

Cancer Medicine

Anna Tavakkoli

Alaina Beauchamp

Tanushree Prasad

Hong Zhu

Amit G Singal

...

2024/2

COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

Gastro Hep Advances

Bhupinder Kaur

Yee Hui Yeo

Jeff Liang

Michael Luu

Walid Ayoub

...

2024/1/1

Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis

Gut

Hashem El-Serag

Fasiha Kanwal

Jing Ning

Hannah Powell

Saira Khaderi

...

2024/2/16

Effect of Hospital Cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal Cancer: A State-Wide Analysis

Annals of Surgical Oncology

Jennie Meier

Gilbert Murimwa

Mithin Nehrubabu

Lisa DiMartino

Amit G Singal

...

2024/1/20

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

Journal of Hepatology

Ciro Celsa

Giuseppe Cabibbo

Claudia AM Fulgenzi

Bernhard Scheiner

Antonio D’Alessio

...

2024/3/1

Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients

JAMA Network Open

Darine Daher

Karim Seif El Dahan

Nicole E Rich

Nabihah Tayob

Vincent Merrill

...

2024/4/1

Racial/ethnic disparities in the effectiveness of atezolizumab plus bevacizumab (A+ B) vs. tyrosine kinase inhibitors (TKIs) among veterans with unresectable hepatocellular …

David Edward Kaplan

Amie Tan

Cheryl Xiang

Fan Mu

Sairy Hernandez

...

2024/1/20

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma

JHEP reports

Lorenz Balcar

Bernhard Scheiner

Claudia Angela Maria Fulgenzi

Antonio D’Alessio

Katharina Pomej

...

2024/2/1

Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis

Hepatology

Manasa Narasimman

Ruben Hernaez

Vanessa Cerda

MinJae Lee

Anubha Sood

...

2024/1/1

Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis

Nikita Sandeep Wagle

Sulki Park

David Washburn

Robert Ohsfeldt

Hye-Chung Kum

...

2024/2/14

INASL Consensus on Management of HCC: Navigating an Evolving Field

Journal of Clinical and Experimental Hepatology

Amit G Singal

Anjana Pillai

Neehar D Parikh

2024/1/1

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Josep M Llovet

Roser Pinyol

Mark Yarchoan

Amit G Singal

Thomas U Marron

...

2024/2/29

See List of Professors in Amit Singal University(University of Texas Southwestern Medical Center)

Co-Authors

H-index: 52
Akbar K. Waljee

Akbar K. Waljee

University of Michigan-Dearborn

H-index: 47
Neehar Parikh

Neehar Parikh

University of Michigan

H-index: 35
Caitlin C Murphy

Caitlin C Murphy

University of Texas Southwestern Medical Center

H-index: 29
Nicole Elizabeth Rich

Nicole Elizabeth Rich

University of Texas Southwestern Medical Center

academic-engine